Mass cytometry by time-of-flight (CyTOF) experiments allow analysis of over 40 functional and phenotypic cellular markers simultaneously at the single-cell level. The data dimensionality escalation accentuates limitations inherent to manual analysis, as being subjective, labor-intensive, slow, and often incapable of revealing the detailed features of each unique cell within populations. The subsequent challenge of examining, visualizing, and presenting mass cytometry data has motivated continuous development of dimensionality reduction methods. As a result, an increasing recognition of inherent diversity and complexity of cellular networks is emerging, with the discovery of unexpected cell subpopulations, hierarchies, and developmental pathways, such as those existing within the immune system. Here, we briefly review some frequently used and accessible mass cytometry data analysis tools, including Principal Component Analysis (PCA), Spanning-tree Progression Analysis of Density-normalized Events (SPADE), tdistributed stochastic neighbor embedding (t-SNE)-based visualization (viSNE) and Automatic Classification of Cellular Expression by Non-linear Stochastic Embedding (ACCENSE), and Cluster Identification, Characterization, and Regression (CITRUS). Mass cytometry together with these innovative analytic tools have the power to lead to key discoveries in investigative dermatology, including but not limited to identifying signaling phenotypes with predictive value for early diagnosis, prognosis, or relapse, and a thorough characterization of intratumor heterogeneity and disease-resistant cell populations, that may ultimately unveil novel therapeutic approaches.
SUMMARY POINTS:
-New methods are being continuously developed to analyze and best represent multi-dimensional, complex CyTOF data. -Principal Component Analysis (PCA) provides a visualization of the data in 3D space and identifies the parameters with the most variance among the dataset. -Spanning-tree Progression Analysis of Density-normalized Events (SPADE) clusters cells into a minimum-spanning hierarchical tree for 2D visualization. -In t-distributed stochastic neighbor embedding (t-SNE)-based visualization (viSNE) and Automatic Classification of Cellular Expression by Non-linear Stochastic Embedding (ACCENSE), each single cell data point has a unique location in a 2D representation, reflecting the cells' immunophenotypic similarity or differences in high dimensional space. -Cluster Identification, Characterization, and Regression (CITRUS) identifies cellular features that correlate to an experimental endpoint of interest.
INTRODUCTION
New methods are being developed to examine, visualize, and present the multidimensional complexity of cellular function, identity, and the role of individual cells within biological systems. Mass cytometry using time-of-flight mass spectrometry (CyTOF) currently has the capacity to allow investigation of 40 or more distinct parameters at the single-cell level (Fig. 1 ). While the technique has not yet been widely adopted within the field of investigative dermatology, it has potential to, for example, allow identification of cell signals for early diagnosis in cutaneous T cell lymphoma, allow early detection or predict relapse in psoriasis and atopic dermatitis, and allow thorough characterization of drug-resistant cell populations in skin cancer, eventually unveiling new therapies.
The large amount of data generated and potential of the technique to delineate rare cell subsets has driven the need to develop dimensionality reduction methods and analysis algorithms to best analyze and represent mass cytometry data. A significant limitation of traditional data clustering methods through biaxial plots and histograms, such as has been used to represent traditional flow cytometry data, is that pre-existing knowledge of the defining markers of each population is required. This limits the ability of researchers to discover unexpected cellular subsets and does not allow examination of system-level phenotypic diversity. Furthermore, manual analysis of individual markers and combinations of markers is a subjective, slow, and labor-intensive process, which results in a significant scalability restriction and can introduce several inherent biases. While CyTOF technology and experimental methodology have been described in detail in previous review 1,2 , comprehensive understanding is also required with respect to the tools available for analysis of high-dimensional datasets in order to make meaningful use of the results. In this short review, we focus on some of the most commonly used and accessible novel CyTOF data analysis tools, including Principal Component Analysis (PCA), Spanning-tree Progression Analysis of Density-normalized Events (SPADE), t-distributed stochastic neighbor embedding (t-SNE)-based visualization (viSNE) and Automatic Classification of Cellular Expression by Non-linear Stochastic Embedding (ACCENSE), and Cluster Identification, Characterization, and Regression (CITRUS). 
DIMENSION REDUCTION AND VISUALISATION ALGORITHMS
Principal component analysis PCA is a well-established and widely used tool to visualize multidimensional data that was adopted to analyze large mass cytometry data sets. [3] [4] [5] PCA identifies those parameters among a certain dataset that present the most variance by generating linear combinations from a large list of parameters into new compound variables (principal components). As a result, the quotient of the relative variation of each principle component over the total variance gives an idea of the effectiveness of each component in separating out data points. In addition, PCA results in models that can be used to project new data points in linear time. For example, it allows graphical visualization of the expression intensity of several functional markers (Y axis) throughout the cell differentiation process (x axis) ( Fig.  2 ). PCA also allows visualization of the data in 3D space, often prominently displaying the first 3 data components of maximal variance. However, this feature can also be a limitation, as it may mask noteworthy biological differences that are more subtle variances in the data. Another constraint is the inherent assumption that the given data are parametric. PCA also represents the data through linear projections, which may not be representative of the inherent structure of the original data. To overcome this constraint, non-linear methods such as t-SNE (described in following sections) were developed for high-dimensional data analysis. 5 This representation method displayed a greater phenotypic and functional complexity among CD8 + T cells than previously appreciated (Fig. 2) . The holistic study of many functional and phenotypic markers and their expression levels through several differentiation subsets would not be possible by conventional manual analysis. This study also observed that subsets that develop in response to different viruses have distinct combinatorial patterns of cytokine expression, showing the remarkable flexibility of CD8 + T cells in responding to pathogens. A similar approach could be used to study the diversity and complexity of skin-specific T cells or innate lymphoid cells (ILCs), complementing the recent in situ topographic characterization of ILCs in human skin. 6 Spanning-tree Progression Analysis of Density-normalized Events In contrast to PCA that draws out the underlying variance within a dataset, the goal of clustering algorithms is to visualize common patterns within data sets. In the context of immunephenotyping, automatic clustering algorithms aim to define the most prevalent cell populations by clustering cells based on markers expression similarity. 7 SPADE was the first algorithm specifically developed for mass cytometry data analysis that includes both clustering and dimension reduction. In SPADE, cells are clustered into a hierarchical tree shape for 2D visualization. 4, 8 Each cluster of a SPADE tree is graphically represented by a circular node, in which the node size symbolizes the frequency of data points within that population (number of hits) and the node color shows the signal intensity of a selected marker (intensity of hit). Each node is connected to related nodes by a minimum-spanning tree (MST) algorithm. MST is a classic computer algorithm that searches for a tree-like graph through a set of spatial nodes by using the least possible number of connections. Such a tree might mimic a relational map of immune cell types in their cell development. This method allows comparison between expression of markers among clusters and across distinct samples in a dimension-reduced big-picture view of diverse cell populations ( Fig. 3) . A limitation of SPADE is that it cannot reproduce the same representation of results when the same data set is analyzed more than once, since the algorithm involves several stochastic steps. The rigid connections established within the data representation structure (graph) may mislead the positioning of some cell nodes, possibly obscuring the underlying biology. Lee et al. (2015) recently utilized CyTOF and SPADE to define in detail the phenotype and functional characteristics of distinct subsets of nasal dendritic cells in mice. 9 SPADE clearly portrayed a map of the vast heterogeneity of nasal dendritic cells and identified new subsets that were not perceptible by manual gating on the basis of canonical marker expression. Moreover, it enabled simultaneous comparison of all subsets prior to and after stimulating factor (FMS)-related tyrosine 3 kinase ligand treatment, revealing which subsets became functionally active and/or expanded in number of cells. t-distributed stochastic neighbor embedding-based visualization and Automatic Classification of Cellular Expression by Non-linear Stochastic Embedding t-SNE allows visualization of high-dimensional data through a non-linear reduction where each data-point is given a location in a 2D or 3D map. 10 Newer t-SNE-based strategies have been developed to visualize complex mass cytometry data: viSNE and ACCENSE. In contrast to PCA, these algorithms effectively capture nonlinear relationships among the data and, unlike SPADE, they do not cluster cells into exclusive nodes. Each single cell data point has a unique location in a 2D representation, similar to a biaxial scatter plot, reflecting their proximity in high dimensional space. viSNE is a graphical user interfaced tool based on t-SNE, while ACCENSE has extended t-SNE with clustering of the resulting 2D scatter data into density-based clusters. Thus, close proximity between any two cells is based on their immunophenotypic similarity pre-defined by input markers. For example, to generate a map of the various memory T-cell subpopulations markers such as CD31, CD45RA, CD45RO, CCR7, or CD62-L can be selected. The algorithm then clusters cells according to their similarity within these markers.
A color scale can then be used to visualize each marker's relative expression in the population. However, this type of representation may obscure subtle density differences among cell populations. Another drawback of these algorithms is the inability to currently analyze large numbers of different samples simultaneously. For example, the current version of the commercial software Cytobank can analyze up to 2 million cells.
Healthy and cancerous bone marrow samples were recently studied using viSNE. Healthy samples were graphically represented and contrasted with cancerous samples that exhibited an abnormal map. Marker expression patterns were analyzed from diagnosis to relapse, allowing identification of disease-specific subsets (Fig. 4 ). 11 ACCENSE helped to further characterize CD8 + T cell subpopulations and identify new subsets that were not noticeable on biaxial plots (Fig. 5 ). 12 
CLUSTERING AND CORRELATION WITH CLINICAL OUTCOME
Cluster Identification, Characterization and Regression CITRUS aims to not only showcase biological mechanisms and hierarchies and define population subsets, similar to previously described algorithms, but also to identify cellular features that correlate to an experimental endpoint of interest. Bruggner et al. (2014) showed that CITRUS accurately identified subsets of cells associated with acquired immune deficiency syndrome-free survival in human immunodeficiency virus-infected patients. 13 CITRUS clusters cells based on similarity of cell markers. Such methods can delineate clusters of cells with specific behavioral characteristics such as those that have activated specific signaling pathways, which can potentially be associated with clinical outcomes such as time to recovery or overall survival after a drug treatment or surgery. By specifying the outcome of interest for each sample from the vast cytometry data uploaded, regularized, statistic algorithms can recognize cells exhibiting behavior predictive of outcome. The phenotype and behaviors of each cluster are delineated through distinct data representations including conventional biaxial plots that can result in a predictive model for the analyses or validation of future samples. In order to run correlation analysis with enough statistical power, CITRUS requires input from more than 8 samples for each group. Gaudillière et al. (2014) applied this method to monitor patients undergoing hip replacement surgery to characterize the phenotypical and functional immune responses predictive of recovery from surgical trauma (Fig. 6) . 14 Since the patient clinical histories of post-surgical recovery were known, CITRUS identified intracellular signaling markers that strongly correlated with recovery from fatigue, functional hip impairment, and pain after surgery. Likewise, CITRUS could be used to analyze immune cell populations and molecular markers from patients with inflammatory or autoimmune diseases before and after receiving biologic treatments. It could reveal which cell subset or markers are predictive of therapeutic outcome, allowing early adjustments to treatment protocols in patients predicted to be non-responders, reducing side effects and costs.
COMMERCIAL SOFTWARE AND PUBLIC PROGRAMS
Following mass cytometry data acquisition, each respective sample must be deconvoluted if samples were initially barcoded and normalized based on calibration beads. CyTOF data can be exported in the form of FCS files, which can be analyzed by standard flow cytometry software such as FCS Express and FlowJo, or by using cloud-based analysis tools, such as Cytobank (www.cytobank.org). Cytobank allows transfer and storage of multiple CyTOF FCS files, attachment of related data including protocols, presentations, annotations and images, and the sharing of data and analysis with chosen collaborators. Additional analytical tools may be needed including but not limited to: dose response, heat maps, SPADE, viSNE, CITRUS, and dot and histogram overlays. viSNE can be publicly licensed to academic users as a matlab-based tool from the Dana Pe'er Lab of computational Systems of Biology webpage (http://www.c2b2.columbia.edu/danapeerlab/html/software.html). The Nolan Laboratory also publically offers some of these algorithms, such as SPADE and CITRUS (https://github.com/nolanlab). ACCENSE is freely offered at (http://www.cellaccense.com) and a PCA algorithm is included in the open-sourced R basic package. These analysis tools may provide different types of biological information about the same data set, making it acceptable to concurrently use distinct tools in a single experiment (Table 1) . Nevertheless, the accessibility to CyTOF analysis tools continues to improve, with numerous groups developing similar and new analysis methods for CyTOF data. Table 1 . Analysis algorithms for mass cytometry data. Principal Component Analysis (PCA), Spanning-tree Progression Analysis of Density-normalized Events (SPADE), t-distributed stochastic neighbor embedding (t-SNE)-based visualization (viSNE) and Automatic Classification of Cellular Expression by Non-linear Stochastic Embedding (ACCENSE), and Cluster Identification, Characterization, and Regression (CITRUS). *The cloud-based software Cytobank viSNE can currently handle up to 2 million cells.
CONCLUSIONS
The continuous development and enhancement of analysis tools for mass cytometry expands our ability to study complex and heterogeneous biological systems at the level of individual cells. This enables our understanding of the progression and development of healthy and pathologic cells, such as in psoriasis, atopic dermatitis, and vitiligo. For example, why do some lesions only reoccur in the same anatomical site? Why are some areas of the body more commonly affected? What distinguishes pathological cells in a stable versus a progressive disease? Disease-specific cell subsets can be identified, characterized, monitored during treatment, and perhaps screened for early biomarkers predictive of relapse risk. Differences may be revealed among cells responsible for the clinical heterogeneity of cutaneous T cell lymphoma, ultimately unveiling disease-specific biomarkers and personalized novel therapeutic approaches. Innovative therapies can be studied to specifically target malignant cell populations resistant to conventional treatments, such as in melanoma. Ultimately, the goal of this article was to demystify the developing tools for mass cytometry and its data analysis so these technologies may be adopted, and results understood to address these and other important research questions in the coming years.
